Reverba selected as a Gold Winner in the 2024 TITAN Business Awards, which recognize the achievements, leadership and innovation of organizations worldwide that are driving industries forward –
Seattle, WA – November 15, 2024 – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced that the company has been selected as a Gold Award winner in the 2024 TITAN Business Awards.
Reverba was recognized in the Business-to-Business category for ReverbaLINK®, the company’s comprehensive digital platform that powers patient engagement solutions for clinical teams in the biopharmaceutical industry.
“We’re honored to be selected as a business leader by the judges of the TITAN Awards,” said Cheryl Lubbert, CEO of Reverba. “This recognition shines a well-deserved spotlight on our ReverbaLINK team and their commitment to innovation. We leverage patient insights, strategic expertise, and innovative communication tools including ReverbaLINK to create deeper connections between patients, healthcare providers, and biopharma. These connections drive our mission to transform personal experience into action to improve human health.”
About the TITAN Awards
The TITAN Awards, hosted by the International Awards Associate (IAA), welcomes participants from across the business spectrum, from entrepreneurs and small businesses to multinational corporations, celebrating excellent work and success. The 2024 Awards competition received more than 1700 submissions globally, across a range of business categories.
About Reverba
Reverba is a global health engagement company that provides solutions to empower the biopharmaceutical industry to build connections with consumers and better meet the needs of patients through innovative technology and patient-centric approaches from discovery through commercialization.
Recently, Reverba expanded its global footprint through the acquisition of Six Degrees Medical, a leading medical communications agency specializing in medical affairs and scientific engagement. This strategic acquisition enhances Reverba’s ability to deliver comprehensive solutions in clinical trials, medical affairs, patient engagement, and scientific communications, further solidifying its leadership in the industry.
For more than 20 years, Reverba has incorporated compliance throughout its technology platforms and patient engagement solutions, maintaining SOC 2 Type II certification for the highest level of security. Formed from the mergers of Health Advocacy Strategies, Patient Health Perspectives, and Health Perspectives Group, the company rebranded as Reverba in 2021. Health Stories Project, a wholly owned subsidiary of Reverba, is a sharing community about personal health experiences, participation in clinical trials, and other activities.
For more information, visit reverba.com or contact partnerships@em.reverba.com.
For media inquiries, please contact:
Kira Gordon
Email: kira@brightpointny.com
Phone: (646) 243-4920
# # #
